MDMA (Methylenedioxymethamphetamine) is a popular psychoactive substance found in the recreational drug ‘Ecstasy’. Despite its frequent mention in the media in relation to demise caused by hyperthermia (overheating, often as a result of dehydration and excessive physical activity) or Buy ambien online hyponatremia (excessive consumption of water, resulting in death), serious MDMA extreme adverse events seem rare : with approximately two in one hundred thousand users having a reaction resulting in death. The real health concern it seems, is not on any given day risks of MDMA. But alternatively the alarmingly large number of habitual and long-term users of MDMA who regularly bump their neurotransmitters ‘out of whack’, every weekend.
This long term abuse is worrying because MDMA is a relatively new drug and as such there have been no studies on long-term MDMA users. Is prejudicial ., MDMA has a very unique basis of mechanism : significantly modifying the serotonin systems of the brain. Furthermore, recent research conducted on both non-human primates and humans has found differences between MDMA user’s brains and performance measures compared to non- MDMA users. MDMA causes an increase in the concentrations of mit of three neurotransmitters in the brain: serotonin (5HT), norepinephrine (NE), and dopamine (DA). Its primary release of serotonin is thought to be the cause of the majority of Ecstasy’s positive side effects (empathy and euphoria), the depression users feel after using the drug and also the neurotoxic changes found in MDMA user’s brains.
These effects come as no surprise, as serotonin is the neurotransmitter primarily responsible for managing feelings, sleep, and mood. Current research on MDMA and the brain has had conflicting and complex results. Animal research has shown much research on MDMA and potential damaging effects it has on the human brain. There is a huge library of literature proving differences in memory, language, and brain functioning between MDMA users and non-users; and non-human experiments showing unusual serotonin axon regrowth in various close innate family of mine. However, much of the current research suffers from poor trial and error design and trial and error controls that are central to any scientific study and all too heavily associated correlation with causation.
Most research on ecstasy users can be categorized into two areas of study: neurofunctional measures and neurocognitive measures. Neurofunctional is loosely used to indicate measures of how the brain is working and measures of the concentration or thickness of neurochemicals. Neurocognitive measures refers to performance on standardized psychological tests of mental abilities. Research on ecstasy users supports associations between MDMA exposure and alterations in both neurofunctional and neurocognitive measures.